Skye Bioscience Income Statement (2012-2014) | SKYE

Income Statement Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jun2014 Dec2014
Revenue & cost
Revenue 0.06M0.11M0.09M0.08M0.06M0.07M
Cost of Revenue 0.01M0.02M0.02M0.02M0.01M0.02M
Gross Profit 0.05M0.09M0.07M0.07M0.05M0.06M
Operating items
Depreciation & Amortization - Total 0.00M
Selling, General & Administrative 93.000.00M0.01M0.01M0.01M0.01M0.01M0.01M0.14M2.48M
Other Operating Expenses 0.01M0.01M0.00M0.03M
Operating Expenses 93.000.01M0.06M0.11M0.09M0.09M0.06M0.09M0.14M2.51M
Operating Income -93.000.00M-0.01M0.00M744.00-0.01M-0.00M-0.01M-0.14M-2.72M
EBIT -93.000.00M-0.01M0.00M744.00-0.01M-0.00M-0.01M-0.14M-2.72M
Non-operating items
Interest & Investment Income 148.00142.00143.00162.0094.00391.00407.00224.00
Non Operating Income 148.00142.000.01M-487.00-0.00M-237.000.00M-83.00
Net income details
EBT 55.000.00M242.000.00M-0.00M-0.01M0.00M-0.01M-0.14M-2.73M
Tax Provisions 82.000.00M-796.00
Profit After Tax 55.000.00M160.000.00M-712.00-0.01M0.00M-0.01M-0.14M-2.73M
Income from Continuing Operations 55.000.00M160.000.00M-712.00-0.01M0.00M-0.01M-0.14M-2.73M
Consolidated Net Income 55.000.00M160.000.00M-712.00-0.01M0.00M-0.01M-0.14M-2.73M
Income towards Parent Company 55.000.00M160.000.00M-712.00-0.01M0.00M-0.01M-0.14M-2.73M
Net Income towards Common Stockholders 55.000.00M160.000.00M-712.00-0.01M0.00M-0.01M-0.14M-2.73M
Additional items
EPS (Basic) 0.000.000.000.000.000.000.000.00-0.02-0.27
Shares Outstanding (Weighted Average) 2.33M2.33M2.96M3.15M3.15M3.12M3.62M3.62M8.13M
EBITDA -93.000.00M-0.01M0.00M0.00M-0.01M-0.00M-0.01M-0.14M-2.72M
Interest Expenses 213.00649.00662.00628.00410.00307.00
Tax Rate 33.88%33.79%52.79%